Provenance Wealth Advisors’s AbbVie ABBV Stock Holding History

Provenance Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$394K	Buy	1,565 +48	+3%	+$10.3K	0.04%	93
2026 Q1	$330K	Hold	1,517	–	–	0.03%	91
2025 Q4	$347K	Hold	1,517	–	–	0.04%	84
2025 Q3	$351K	Hold	1,517	–	–	0.05%	87
2025 Q2	$282K	Sell	1,517 -33	-2%	-$6.13K	0.04%	96
2025 Q1	$325K	Sell	1,550 -642	-29%	-$125K	0.05%	96
2024 Q4	$390K	Sell	2,192 -7,454	-77%	-$1.37M	0.05%	103
2024 Q3	$1.9M	Sell	9,646 -123	-1%	-$23K	0.24%	36
2024 Q2	$1.68M	Hold	9,769	–	–	0.23%	34
2024 Q1	$1.78M	Sell	9,769 -65	-0.7%	-$11.2K	0.25%	30
2023 Q4	$1.52M	Sell	9,834 -290	-3%	-$42.3K	0.21%	35
2023 Q3	$1.51M	Buy	+10,124	New	+$1.49M	0.24%	30

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Provenance Wealth Advisors's ABBV Position: Q2 2026 in Review

Provenance Wealth Advisors increased its AbbVie (ABBV) stake by 3.2% in Q2 2026, buying an estimated $10.3K and bringing the position to 1,565 shares worth $394K. The position accounts for 0.04% of the portfolio, ranked #93.

Provenance Wealth Advisors first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.9M in Q3 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Provenance Wealth Advisors held 1,565 shares of AbbVie worth $394K as of Q2 2026.
Provenance Wealth Advisors bought 48 AbbVie shares in Q2 2026, an estimated $10.3K.
AbbVie made up 0.04% of Provenance Wealth Advisors's portfolio in Q2 2026, its #93 holding.
Provenance Wealth Advisors first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
Provenance Wealth Advisors's AbbVie position peaked at $1.9M in Q3 2024.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Provenance Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.